Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > leedejones viewpoint...not Salley's though

<< Previous

Bullboard Posts

Next >>

Comment by MustangSalleyon Aug 08, 2021 8:10pm

126 Views

Post# 33670168

RE:leedejones viewpoint...not Salley's though

Mudlogger1 wrote: https://leedejonesgable.com/wp-content/uploads/SVA_2021_06_29.pdf

Of course it's LJG point of view . They shorted it and introduced the same target price of $2.50 after getting in at $1.20 with one full free warrant. They already fleeced Toleikis once and now need to cash in on the bought deal. No surprise or conflict there . Loe doesn't seem to think the competition is dead though as management seems to tell its investors differently .

Nothing in the report we did not know . Too bad Loe did not post the results from AGM instead of his 30% discount rate on $2.50 target .

Ms Sally

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China